This truncated COQ9 protein may produce a dominant-negative or gain-of-function effect, as it has been reported in other mitochondrial diseases (Tyynismaa et al, 2009; Torres-Torronteras et al, 2011). This evidence concerns the gene COQ9 and inborn mitochondrial metabolism disorder.